Skip to main content

Medical Physics Seminar

Chongzhao Ran, PhD

Event Details

Date
Monday, October 10, 2022
Time
4-5 p.m.
Description
The number of preclinical and clinical drug candidates for Alzheimer’s disease (AD) is dwarfed by cancer drugs at similar stages, by a factor of 100. One important contributor for this dire situation is the lack of reliable, low-cost, and efficient tools to assess treatment endpoints and disease progression in AD models.
Cost
Free

Tags